Table 1.
Group‐averaged means (with SD) of measures
| Measures | Baseline (n = 18) | 6 Weeks (n = 18) | Paired t‐test and effect size |
|---|---|---|---|
| VO2peak | 34.9 ± 4.6 | 39.3 ± 5.0 | P < 0.001, d = 0.894 |
| AUCRest Sqrt Transform | 2.19 ± 0.51 | 2.11 ± 0.60 | P = 0.541, d = 0.144 |
| AUCActive | 8.54 ± 3.46 | 8.59 ± 2.77 | P = 0.933, d = 0.016 |
| ICF | 1.30 ± 0.27 | 1.15 ± 0.19 | P = 0.048, d = 0.656 |
| SICI | 0.52 ± 0.25 | 0.50 ± 0.20 | P = 0.752, d = 0.088 |
| BDNF Sqrt Transform | 4.21 ± 1.06 | 4.37 ± 0.95 | P = 0.549, d = 0.159 |
| IGF‐1 | 160.90 ± 41.15 | 154.50 ± 35.10 | P = 0.198, d = 0.167 |
| Total CTSB | 30.32 ± 12.17 | 31.77 ± 11.85 | P = 0.133, d = 0.121 |
| Pro‐CTSB | 15.39 ± 6.45 | 15.93 ± 6.72 | P = 0.391, d = 0.082 |
| OSPAN | 49.67 ± 13.51 | 53.11 ± 11.57 | P = 0.142, d = 0.274 |
AUC, area under the curve; BDNF, brain‐derived neurotrophic factor; CTSB, cathepsin B; ICF, intracortical facilitation; IGF‐1, insulin‐like growth factor 1; OSPAN, operation span task; SICI, short‐interval intracortical inhibition; VO2peak, peak oxygen uptake. Bold font indicates statistical significance.